Rezolute RZLT
NASDAQ RZLT
$3.93 +0.23 (+6.22%)
As of: Oct 22, 2026 · 10:01 AM EDT

Rezolute (RZLT) EBITDA Margin (2019 - 2020)

Updated

Analysis

Rezolute (RZLT) EBITDA Margin (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,157.52 Bn 1,126.11 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 631.39 Bn 549.92 Bn 17.26 Bn 35.95%
3 AbbVie 498.93 Bn 472.04 Bn 12.70 Bn 49.01%
4 Merck 376.05 Bn 330.42 Bn 12.21 Bn 6.02%
5 Novartis Ag 301.98 Bn 265.97 Bn 11.24 Bn -
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn 33.11%
7 Amgen 240.27 Bn 195.67 Bn 7.24 Bn 46.01%
8 Gilead Sciences 193.08 Bn 167.27 Bn 6.22 Bn -124.26%
9 Pfizer 171.85 Bn 118.50 Bn 10.94 Bn 39.16%
10 Rezolute 407.32 Mn -105.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -120,666.67%
Jun 30, 2020 -70,960.00%
Mar 31, 2020 -16,883.33%
Dec 31, 2019 -12,437.04%
Jun 30, 2019 -6,489.80%
Mar 31, 2019 -138,037.42%
API Access

Rezolute EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RZLT&period=max&api_key=YOUR_API_KEY